Choice of therapy for HER2-positive metastatic breast cancer in real clinical practice: analysis of physician preferences in Russian Federation

E. V. Artamonova; E. V. Lubennikova

Medical alphabet
Medicinskij alfavit

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

User

eng | рус

Medical alphabet

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Artamonova E.V., Lubennikova E.V. Choice of therapy for HER2-positive metastatic breast cancer in real clinical practice: analysis of physician preferences in Russian Federation. Diagnostics and Oncotherapy (3). 2024;(27):60-66. (In Russ.) https://doi.org/10.33667/2078-5631-2024-27-60-66

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles Editors' Choice

Editor-in-Chief

Petrikov Sergey S.

Subscription Login to verify subscription

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

E. V. Artamonova
N.N. Blokhin National Medical Investigation Centre of Oncology; Dept of Oncology and Radiation Therapy at Pirogov Russian National Research Medical University; Dept of Oncology and Thoracic Surgery at M. F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation

Artamonova Elena V., DM Sci (habil.), head of Dept of Antitumor Drug Therapy No.1 Dept of Drug Treatment; professor at Dept; head of Dept

Moscow

E. V. Lubennikova
N.N. Blokhin National Medical Investigation Centre of Oncology
Russian Federation

Lubennikova Elena V., PhD Med, senior researcher at Dept of Antitumor Drug Therapy No.1 Dept of Drug Treatment

Moscow

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Medical alphabet

For citations:

Cookies policy